Arachidonic acid (ARA), a potent nSMase activator, was shown to attenuate leukemia-derived HL-60, gastric, prostate and breast cancer cells growth via nSMase activation pathways [111–113]. This evidence concerns the gene SMPD2 and breast carcinoma.